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OBJECTIVES: To examine the relationship between
objectively measured physical activity (PA) and cognitive
function in white and black older adults.
DESIGN: Cross-sectional.
SETTING: REasons for Geographic and Racial Differ-
ences in Stroke (REGARDS) study.
PARTICIPANTS: Older adults who provided valid data
from accelerometer and cognitive function tests (N = 7,098).
MEASUREMENTS: Accelerometers provided estimates of
PA variables for 4 to 7 consecutive days. PA cut-points of
50 counts per minute (cpm) and 1,065 cpm were applied
to differentiate between being sedentary and light PA and
between light and moderate to vigorous PA (MVPA),
respectively. Prevalence of cognitive impairment was
defined using the Six-Item Screener (<4/6). Letter fluency,
animal fluency, word list learning, and Montreal Cognitive
Assessment (orientation and recall) were used to assess
memory and executive function.
RESULTS: Of 7,098 participants (aged 70.1  8.5, 54.2%
female, 31.5% black), 359 (5.1%) had impaired cognition
within 12 months of PA measurement. The average pro-
portion of time spent in MVPA (MVPA%) was
1.4  1.9%. Participants in the highest quartile of MVPA%
(~258.3 min/wk) were less likely to be cognitively impaired
than those in the lowest quartile (odds ratio = 0.65, 95%
confidence interval = 0.43–0.97). MVPA% was also signifi-
cantly associated with executive function and memory
z-scores (P < .001). Similar analyses of proportion of time
spent in light PA (LPA%) and sedentary time (ST%) showed
no significant associations with cognitive function.
CONCLUSION: Higher levels of objectively measured
MVPA%, rather than LPA% or ST%, were associated
with lower prevalence of cognitive impairment and better
performance in memory and executive function in aging
people. The amount of MVPA associated with lower
prevalence of cognitive impairment is consistent with meet-
ing PA guidelines. J Am Geriatr Soc 63:2447–2454, 2015.
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A growing body of evidence indicates increasing preva-lence and incidence of cognitive impairment in older
adults in the United States.1 A national study reported that
an estimated 5.4 million people in the United States aged
70 and older had mild cognitive impairment (MCI).2 Of
those who completed follow-up assessments in the study,
11.7% with MCI progressed to dementia annually. A
recent study showed that the prevalence of dementia in
older adults in the United States in 2010 was 14.7%.3 The
cost of dementia in 2010 was $157 billion to $215 billion,
with $11 billion associated with direct medical care. Cog-
nitive impairment is a substantial financial liability on soci-
ety similar to that of heart disease and cancer. Effective
prevention strategies will have significant public health
implications by improving quality of life and reducing eco-
nomic cost and social burden.
Regular physical activity (PA) provides benefits for
cognitive health and helps to improve or maintain quality
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of life of older adults.4 Research suggests that more-active
individuals have less risk of cognitive impairment or
dementia.5,6 Cognitive impairment was more prevalent in
community-dwelling older adults reporting no PA than in
those reporting moderate and high PA levels.7 Higher self-
reported PA levels in early life were associated with less
risk of MCI in later life,8,9 although methodological differ-
ences in PA assessment preclude comparisons of studies of
the optimal pattern of PA to reduce the risk of cognitive
decline. Most previous studies were based on self-reported
PA assessments,7,10,11 which are subject to reporting and
recall biases. Furthermore, there are important differences
in PA between racial groups,12–14 with blacks significantly
understudied in terms of the association between PA and
cognitive function.15
Thus, the purpose of this study was to investigate the
association between objectively measured PA and cognitive
function in older adults according to sex and race. It was
hypothesized that there would be a significant, positive
dose-response association between PA measured using
accelerometers and cognitive function in a representative
sample of white and black older adults in the United
States.
METHODS
Design and Procedures
This study was ancillary to the REasons for Geographic
and Racial Differences in Stroke study (REGARDS), a
national epidemiological study that enrolled and is follow-
ing a cohort of 30,239 black and white adults to assess
the prevalence and incidence of stroke and cognitive
decline in the continental United States The cohort was
recruited using a combination of mail and telephone con-
tact from January 2003 to October 2007. Risk factors
were assessed in a telephone interview, followed by an in-
person physical assessment 3 to 4 weeks later. Participants
were contacted by telephone every 6 months for incident
stroke events, annually for cognitive screening status, and
every 2 years for more-detailed cognitive assessments. The
detailed design and methods for REGARDS have been
described previously.16
This ancillary study was conducted from May 2009 to
January 2013 during follow-up of the cohort. A question
was added to the 6-month telephone follow-up asking par-
ticipants whether they were willing to wear an accelerome-
ter and complete a daily activity log for 1 week. Upon
acceptance, an accelerometer and log sheet were mailed to
participants with instructions and then mailed back for
processing. The detailed design of and methods for the
ancillary study have been described elsewhere.17 The insti-
tutional review boards of Arizona State University, Univer-
sity of South Carolina, University of Georgia, and
University of Alabama at Birmingham approved the study.
Baseline information obtained from the parent
REGARDS dataset included age, sex, race, region of resi-
dence (living within or outside the stroke belt), education,
body mass index (BMI), smoking status (self-reported cur-
rent smoking or not), hypertension (systolic blood pressure
≥140 mmHg, diastolic blood pressure ≥90 mmHg, or self-
reported current medication use to control blood pressure),
and diabetes mellitus (self-reported disease or current med-
ication use) for purposes of describing the sample and con-
trolling for possible confounders.
PA Measures
PA monitors (Actical, Mini Mitter Respironics, Inc., Bend,
OR) provided real-time estimates of the frequency, inten-
sity, and duration of PA. Accelerometers were attached to
a neoprene waistband and worn over the right hip. Partici-
pants were asked to put on the device after waking up
each morning and take it off just before going to bed each
evening and were instructed to wear the device for 7 con-
secutive days and return the device immediately after. For
all participants with valid data, time in sedentary behavior,
light PA (LPA), and moderate to vigorous PA (MVPA) and
proportions of total wear time spent in sedentary behavior
(ST%), light PA (LPA%), and MVPA (MVPA%) were
determined. Activity count cut-points of 50 counts per
minute (cpm) and 1,065 cpm were applied to differentiate
between being sedentary and light PA and between light
PA and MVPA, respectively.18 Details of the accelerometer
data management and analysis have been published previ-
ously.17,18
Cognition Assessment
Cognitive function was assessed during telephone inter-
views using standardized scripts and scoring methods
described previously.19 Cognitive impairment was defined
according to each participant’s score on the Six-Item
Screener (SIS), a test of global cognitive function with
established reliability and validity in community samples
and in black and white adults.20 The SIS included 6 ques-
tions: What year is this? What month is this? What is the
day of the week? What were the three objects I asked you
to remember (apple, table, penny)?” Scores on the SIS
range from 0 to 6, with a score of 4 or fewer correct
responses indicating cognitive impairment.20 Sensitivity
analyses were conducted,19 and it was decided to use cog-
nitive assessments within a time range of 12 months of
wearing the accelerometer to obtain the largest sample size
and shortest time intervals between PA measurements and
cognitive tests.
Four expanded cognitive battery tests with demon-
strated usefulness in early identification of Alzheimer’s dis-
ease or dementia were also used:21 the Word List Learning
(WLL) and semantic fluency (animals fluency, AF) from
the Consortium to Establish a Registry for Alzheimer’s
Disease battery,21 letter fluency (LF), and the recall and
orientation items from the Montreal Cognitive Assessment
(MoCA).22 These tests assess domains of memory (WLL,
MoCA recall and orientation) and executive function (AF,
LF). Acceptable reliability and validity of these tests have
been previously reported.21,23 Analyses of these measures
were restricted to the most-recent results obtained within
12 months of PA measurement. Composite measures of
two cognitive domains (memory and executive function)
were created by converting each test into a z-score based
on the mean and standard deviation for that specific test’s
results in all participants. The mean of the z-scores of
memory and executive function was calculated as an over-
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all cognitive z-score, presenting the average level of mem-
ory and executive domains. For participants missing one
test score or z-score, the other available records were used
to calculate domain and cognitive battery z-scores.
Participants
Of the REGARDS cohort, 12,146 (60.5%) agreed to com-
plete the accelerometer protocol, 7,312 (36.4%) declined,
and 618 (3.1%) were deferred and did not have the oppor-
tunity to be asked again during the enrollment period. Of
the devices that were mailed, 972 (8.0%) were lost or not
returned, 1,187 (9.8%) were returned not worn, 14
(0.11%) were returned and found to be defective such that
no data could be downloaded, and 9,973 (82.1%) were
returned with data. Of the 9,973 participants who
returned and wore the accelerometer, 8,096 (81.1%) pro-
vided usable data, after exclusions for device error, missing
log sheet, and wear time of less than 4 days or less than
10 hours per day.17
Seven thousand ninety-eight of the 8,096 participants
were included in the present analyses. Participants were
excluded if they self-reported stroke at baseline (n = 264),
were identified as cognitively impaired more than
12 months before PA assessment (n = 383), had an inci-
dent stroke before wearing the accelerometer (n = 6), or
had no record of valid PA measurement associated with
SIS assessment within 12 months of PA assessment
(n = 345).
Statistical Analysis
Continuous data expressed as MVPA (min/wk) and MVPA
% was extremely skewed (e.g., 20% of the entire sample
recorded <1 min/d of MVPA), violating the assumptions of
linear regression and not providing a true measure of asso-
ciations with the dependent variables. Thus, the primary
independent variable of MVPA% was divided into quar-
tiles, allowing for group comparisons and investigation of
possible dose-response associations in the presence of
skewness. Because of inherent variability in daily
accelerometer wear time, MVPA% rather than absolute
time spent in MVPA was used as the standard for quartiles
to render results comparable among individuals. Depen-
dent variables were cognitive status (impairment or not)
measured using the SIS and z-scores generated from WLL,
AF, LF, and MoCA recall and orientation. Differences in
demographic variables between quartiles were tested using
analysis of variance (continuous variables) or chi-square
tests (categorical variables). Because the SIS was validated
using dichotomous outcomes rather than continuous
scores,20 associations between MVPA% and cognitive
impairment were examined using multivariable logistic
regression models. In the logistic models, Model 1 was
unadjusted; Model 2 was adjusted for age, sex, race,
region of residence, and education; and Model 3 was
adjusted for age, sex, race, region of residence, education,
ST%, BMI, hypertension, smoking, and diabetes mellitus.
Odds ratios (ORs) and 95% confidence intervals (CIs)
were generated. Linear regression models with adjustments
for potential confounders similar to those mentioned above
were used to assess the association between MVPA% and
z-scores generated from WLL, AF, LF, and MoCA recall
and orientation. Differences in z-scores of memory and
executive function between quartiles and racial and sex
subgroups were examined after full adjustment of con-
founders. Analyses were conducted using SAS version 9.3
(SAS Institute, Inc., Cary, NC).
RESULTS
Demographic characteristics, PA, and cognitive function
are shown in Tables 1 and 2 according to quartiles of
MVPA%. Of the 7,098 participants, 54.2% were female,
31.5% were black, 54.9% were living in the Stroke Belt,
and 5.1% had impaired cognitive status at the assessment
within 12 months of the PA measurement. The mean
time  standard deviation between PA assessment and
each cognitive assessment was 5.4  3.8 months. The
mean age of all participants was 70.1  8.5, and they
wore the accelerometer for 6.6  0.8. Participants spent
most of their wear time in sedentary behavior
(69.9  8.1%) and LPA (26.6  7.7%). MVPA% was
extremely limited (1.5  1.9%). There were significant dif-
ferences between quartiles of MVPA% in all variables
listed in Table 2 (P < .001). Participants with higher
MVPA% were more likely to be male, white, younger,
well educated, and nonsmokers; not to have diabetes melli-
tus, hypertension, or cognitive impairment; and to have
lower BMI and systolic and diastolic blood pressure. Par-
ticipants in the higher MVPA% quartiles also spent more
time in LPA and had higher raw WLL, AF, LF, and MoCA
recall and orientation scores. Higher MVPA% was associ-
ated with lower prevalence of cognitive impairment as
measured using the SIS. Fewer individuals had cognitive
impairment in the highest MVPA% quartile (2.9%) than
in the lowest (15.0%).
Results of logistic regression analyses are displayed in
Table 3. In the unadjusted model (Model 1), participants
in the highest MVPA% quartile were 63% less likely to
have cognitive impairment than those in the lowest quar-
tile. After adjustment for age, sex, race, region of resi-
dence, and education (Model 2), this association remained
significant. Participants in the highest quartile were 36%
less likely to have cognitive impairment (OR = 0.64, 95%
CI = 0.44–0.93). There were no significant interactions
(age*MVPA%, sex*MVPA%, race*MVPA%, education
*MVPA%, region*MVPA%), so these were not included
in the analytical models. In the fully adjusted model
(Model 3), results were consistent with Model 2, with par-
ticipants in the highest MVPA% quartile 37% less likely
to have cognitive impairment (OR = 0.63, 95%
CI = 0.43–0.93). Similar analyses with LPA% and ST%
did not reveal any significant associations (P > .05) with
the odds of cognitive impairment. Additionally, logistic
regression analysis categorizing participants as accumulat-
ing more or less than 150 min/wk of MVPA indicated that
older adults were 36% less likely to have cognitive impair-
ment if they accumulated 150 min/wk or more of MVPA
(OR = 0.64, 95% CI = 0.44–0.91) after full adjustment.
Subgroup logistic analyses were conducted for each race
and sex group, but significance was not maintained. When
using MVPA% as a continuous variable, there was no sig-
nificant association between MVPA% and prevalence of
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cognitive impairment when adjusted for confounders in
Models 2 and 3 (P > .05).
Four thousand four hundred forty-one participants
had at least one test of AF or LF in the domain of execu-
tive function (with 3,412 (77%) of those having both
tests), and 5,178 participants had at least one test of WLL
or MoCA items in the domain of memory (with 3,977
(77%) of those having both tests). Additionally, 5,188 par-
ticipants had at least one z-score of memory or executive
function (with 4,431 (85%) of those having both tests).
Linear regression models (Table 4) revealed a significant
association (P < .001) between MVPA% and both cogni-
tive function domains in the unadjusted model. These rela-
tionships remained significant when controlling for age,
sex, race, region of residence, and education, and there
were no significant interactions between MVPA% and
these confounders (P > .05). When analyses were further
adjusted for BMI, hypertension, smoking, and diabetes
mellitus, MVPA% remained significantly associated with
of executive function and memory z-scores and their aver-
age combined score for overall cognitive function. Linear
regression models using MVPA% as a continuous variable
were also developed. Significance was maintained for the
association between MVPA% and executive function,
memory, and overall cognitive function z-scores in all
models (P < .05).
The association between MVPA% and memory and
executive function varied across different racial and sex
subgroups (Table 5). For white men, memory and execu-
tive function z-scores were significantly positively associ-
Table 1. Characteristics of Participants According to Level of Moderate to Vigorous Physical Activity (N = 7,098)
Characteristics Quartile 1 Quartile 2 Quartile 3 Quartile 4 Total
Female, n (%) 1,164 (65.7) 1,026 (57.8) 904 (51.0) 750 (42.1)a 3,844 (54.2)
African American, n (%) 749 (42.3) 611 (34.4) 495 (28.0) 379 (21.3)a 2,234 (31.5)
Stroke belt, n (%) 991 (56.0) 1,001 (56.4) 989 (55.8) 913 (51.3)a 3,894 (54.9)
Education, n (%)
<High school 203 (11.5) 111 (6.3) 85 (4.8) 48 (2.7) 447 (6.3)
High school graduate 544 (30.7) 445 (25.1) 366 (20.7) 263 (14.8) 1,618 (22.8)
Some college 486 (27.4) 561 (31.6) 469 (26.5) 385 (21.6) 1,901 (26.8)
≥College graduate 538 (30.4) 659 (37.1) 851 (48.1) 1,084 (60.9)a 3,132 (44.1)
Smoking, n (%) 255 (14.4) 219 (12.3) 165 (9.3) 112 (6.3)a 751 (10.6)
Hypertension, n (%) 1,224 (69.1) 987 (55.6) 831 (46.9) 657 (36.9)a 3,699 (52.1)
Diabetes mellitus, n (%) 454 (25.6) 308 (17.3) 215 (12.1) 162 (9.1)a 1,139 (16.1)
Age, mean  SD 75.2  8.1 70.9  7.7 68.1  7.8 66.3  7.7a 70.1  8.5
Body mass index, kg/m2, mean  SD 30.1  6.4 29.3  5.8 28.3  5.3 26.9  4.6a 28.6  5.7
Systolic blood pressure, mmHg, mean  SD 130.1  16.3 126.4  15.5 124.4  14.7 121.5  14.3a 125.6  15.6
Diastolic blood pressure, mmHg, mean  SD 76.4  9.6 76.3  9.5 76.3  9.0 75.8  8.8a 76.2  9.2
Quartiles are proportion of total time spent in moderate to vigorous physical activity.
aSignificant difference between quartiles (P < .001), tested using analysis of variance (continuous variables) or chi-square tests (categorical variables).
SD = standard deviation.
Table 2. Physical Activity and Cognitive Function According to Level of Moderate to Vigorous Physical Activity
(MVPA) (N = 7,098 Unless Otherwise Noted)
Variable Quartile 1 Quartile 2 Quartile 3 Quartile 4 Total
Adherence, days with valid wear, mean  SD 6.4  0.9 6.6  0.8 6.6  0.7 6.7  0.7d 6.6  0.8
Total wearing time, min/d, mean  SD 868.3  117.0 885.4  104.1 897.8  99.7 910.1  92.9d 890.4  104.9
Moderate to vigorous physical activity, min/d, mean  SD 0.4  0.4 3.3  1.5 11.1  3.8 36.9  19.5d 12.9  17.5
Light physical activity, min/d, mean  SD 117.0  58.3 181.9  60.7 213.8  68.3 235.0  69.7d 186.9  78.4
Sedentary time, min/d, mean  SD 750.9  119.5 700.2  108.5 672.9  105.9 638.3  107.1d 690.5  117.8
Percentage of wear time in MVPA, mean  SD 0.05  0.05 0.37  0.15 1.23  0.39 4.05  2.10d 1.42  1.91
Percentage of wear time in light physical activity, mean  SD 13.6  6.6 20.7  6.9 24.0  7.5 26.0  7.7d 21.1  8.6
Percentage of wear time in sedentary behavior, mean  SD 86.4  6.6 78.9  6.9 74.8  7.5 69.9  8.1d 77.5  9.5
Cognitively impaired, n (%)a 134 (7.6) 103 (5.8) 70 (4.0) 52 (2.9)d 359 (5.1)
Letter fluency score, meanSD (n = 3,405) 10.3  4.3 11.2  4.5 11.4  4.5 12.3  4.8d 11.3  4.6
Animal fluency score, mean  SD (n = 4,353) 14.9  5.1 16.7  5.0 17.6  5.6 19.4  5.7d 17.1  5.6
Word list learning sum score, mean  SD (n = 3,847)b 16.4  5.1 17.7  5.1 18.9  4.8 19.5  4.5d 18.1  5.0
Montreal Cognitive Assessment c recall and orientation,
mean  SD (n = 5,160)
9.6  1.6 10.0  1.3 10.1  1.2 10.2  1.2d 10.0  1.4
Quartiles are proportion of total time spent in MVPA.
a≤4 correct responses on six-item screener consisting of a three-item recall and three-item temporal orientation.
bFrom the Consortium to Establish a Registry for Alzheimer’s Disease battery (range 0–30).
cFive-word delayed memory recall test and six-item orientation test.
dSignificant difference between quartiles (P < .001) tested using analysis of variance (continuous variables) or chi-square test (categorical variables).
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ated with MVPA% (P < .001). For white women, signifi-
cant differences existed between Quartiles 1 and 3 and
between Quartiles 1 and 4 for executive function
(P < .001). For black men, significant differences existed
between Quartiles 1 and 3 and between Quartiles 1 and 4
for memory (P < .001). No significant differences were
observed between any domains for black women
(P > .05).
DISCUSSION
To the knowledge of the authors, this is one of the first
studies to examine the dose-response relationship between
objectively measured PA and cognitive function in a large
and diverse older population. Objectively measured MVPA
(absolute min/wk and MVPA%) was independently associ-
ated with cognitive impairment and continuous measures
of cognitive function in a population of 7,098 older white
and black adults. The odds of cognitive impairment were
lowest in those in the highest MVPA% quartile (36.9 min/
day (258.3 min/wk) of MVPA, above that recommended
in U.S. national guidelines (>150 min/wk)).24 Older adults
with a greater proportion of accelerometer wear time spent
in MVPA also had better memory and executive function
than their less-active peers.
Cross-sectional and prospective studies5,6 using self-re-
ported PA measurements suggest that more-active individ-
uals may be less likely to develop cognitive impairment
and dementia. A metaanalysis of 16 prospective studies
using self-reported PA indicated that the relative risks of
incident dementia and Alzheimer’s disease in the highest
PA category were 28% and 45% lower, respectively, than
in the lowest PA category,25 although the bias of self-re-
port measures of PA have limited most previous studies of
the relationship between PA and cognitive function, and
these studies have had difficulty identifying effects of LPA
and sedentary time on cognitive function.
A few studies with objectively measured data have
also reported that active older adults may have a lower
prevalence of cognitive impairment or dementia.26–29 One
cross-sectional study of 2,735 older women showed that
daytime PA measured using accelerometers was associated
with lower odds of cognitive impairment.26 Another cross-
sectional study of 217 older adults indicated a dose-re-
sponse relationship between objectively measured PA
intensity and cognitive function, with a stronger associa-
tion between MVPA and cognitive function.27 Another
study5 reported that a higher level of total daily PA, mea-
sured using accelerometers, was significantly associated
with lower risk of Alzheimer’s disease in 716 white indi-
viduals aged 55 and older during 4 years of follow-up.
Higher baseline aerobic fitness levels predicted better per-
formance on measures of attention and executive function
6 years later in 349 adults aged 5 and older.28 Neverthe-
less, the sample sizes of studies with objective PA assess-
ment were small and included fewer nonwhite
participants.
Table 3. Likelihood of Cognitive Impairment Accord-
ing to Level of Moderate to Vigorous Physical Activity
(MVPA)
MVPA
Model 1a Model 2b Model 3c
Odds Ratio (95.0% Confidence Interval)
Percentage of time spend in MVPA (reference Q1 (low)
Q2 0.76 (0.58–0.99) 0.99 (0.75–1.31) 0.97 (0.71–1.31)
Q3 0.52 (0.39–0.70) 0.78 (0.56–1.07) 0.74 (0.51–1.07)
Q4 (high) 0.37 (0.27–0.51) 0.64 (0.44–0.93) 0.63 (0.43–0.93)
Weekly
MVPA ≥150
minutesd
0.43 (0.31–0.61) 0.63 (0.44–0.89) 0.64 (0.44–0.91)
aUnadjusted regression model.
bAdjusted for age, sex, race, region of residence, and education.
cAdjusted for age, sex, race, region of residence, education, proportion of
time spent in sedentary behavior, body mass index, hypertension, smok-
ing, and diabetes mellitus.
dThe U.S. Physical Activity Guidelines recommend that older adults per-
form ≥150 minutes of MVPA per week.24
Table 4. Linear Regression Model Indicating Associa-
tion Between Moderate to Vigorous Physical Activity
and Z-scores of Expanded Cognitive Battery Tests
Cognitive Function
Model 1a Model 2b Model 3c
Beta (Standard Error) P-Value
Average overall cognitive z-score (reference Q1 (low)) (N = 5,188)d
Q2 0.32 (0.03)
<.001
0.13 (0.03)
<.001
0.15 (0.03)
<.001
Q3 0.46 (0.03)
<.001
0.19 (0.03)
<.001
0.16 (0.03)
<.001
Q4 (high) 0.63 (0.03)
<.001
0.27 (0.03)
<.001
0.23 (0.03)
<.001
Executive function z-score (reference Q1 (low) (N = 4,441)e
Q2 0.30 (0.04)
<.001
0.13 (0.03)
<.001
0.11 (0.03)
.003
Q3 0.46 (0.04)
<.001
0.17 (0.03)
<.001
0.13 (0.04)
.001
Q4 (high) 0.71 (0.04)
<.001
0.29 (0.04)
<.001
0.25 (0.04)
<.001
Memory z-score (reference Q1 (low)) (N = 5,178)f
Q2 0.32 (0.03)
<.001
0.20 (0.03)
<.001
0.19 (0.03)
<.001
Q3 0.46 (0.03)
<.001
0.21 (0.03)
<.001
0.19 (0.04)
<.001
Q4 (high) 0.63 (0.03)
<.001
0.26 (0.04)
<.001
0.24 (0.04)
<.001
Quartiles are quartiles of proportion of total time spent in moderate to
vigorous physical activity.
aUnadjusted regression model.
bAdjusted for age, sex, race, region of residence, and education.
cAdjusted by age, sex, race, region of residence, education, proportion of
time spent sedentary, body mass index, hypertension, smoking, and dia-
betes mellitus.
dAverage cognitive z-score refers to average of mean executive score and
mean memory score.
eExecutive z-score refers to average of standardized scores of letter fluency
and animal fluency tests. For participants with only one executive test, the
mean score would be the result of that test.
f Memory z-score refers to average of standardized scores of word list
learning and Montreal Cognitive Assessment five-word delayed memory
recall and six-item orientation tests. For participants with only one execu-
tive test, the mean score would be the result of that test.
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To the knowledge of the authors, the association
between PA and cognitive function remains robust in older
adults when adjusted for race, sex, education, and age,30–
32 but few investigations have investigated the relationship
between PA and cognitive function in specific racial and
sex subgroups. Although interaction terms were nonsignifi-
cant, exploratory analyses (Table 5) indicated that the
association between MVPA% and memory and executive
function may vary according to racial and sex subgroups.
Additional prospective and intervention studies are needed
to investigate the contributions of race and sex to the asso-
ciation between PA and cognitive function in diverse older
adults.
These findings regarding LPA% and ST% revealed no
relationships to cognitive function. MVPA% was the only
PA element displaying a significant dose-response relation-
ship with cognitive function in this population, suggesting
that intensity may be an important factor influencing the
relationship between PA and cognitive function in older
adults. This finding was consistent with previous studies
using self-reported PA.33,34 Only one study using
accelerometers has reported intensity of PA as important
in the association between PA and cognitive function in
older adults, with participants in the highest tertile of PA
intensity performing better than those in the lowest tertile
on cognitive tasks related to memory and executive func-
tion.35
The influence of LPA and sedentary behavior on cog-
nitive function is not fully known. One cross-sectional
study documented that LPA was not significantly associ-
ated with memory and executive function in older adults
after adjustments for confounders.27 Another longitudinal
study in Japan determined that self-reported LPA and
sedentary time were associated with cognitive impairment
after 8 years of follow-up.36 Previous research also indi-
cated that diverse types of sedentary behaviors might be
differently associated with cognitive function.37 Amount of
computer use was positively associated with memory and
executive function, whereas television viewing time was
negatively associated with cognitive function in older
adults.38,39 It was not possible to record the type of seden-
tary behavior in the current study. Additional investiga-
tions are necessary to more fully explore the effect of
sedentary behavior and LPA on cognitive function in older
adults because this is how they spend the vast majority of
their time.
PA may be related to cognitive function through dif-
ferent mechanisms. Research suggests that PA is associated
with greater brain volume in specific areas related to exec-
utive function and memory (e.g., hippocampus vol-
ume),40,41 higher brain-derived neurotrophic factor
levels,42,43 greater cerebrovascular function, and lower vas-
cular risk associated with hypertension, type 2 diabetes
mellitus, and obesity.44 Moreover, studies suggest that sig-
nificant changes in cardiorespiratory fitness may affect cog-
nitive function and risk of dementia.45
This study had several strengths. First and most impor-
tant, an objective measure of PA was used to examine the
Table 5. Adjusted Z-Scores for Cognitive Battery Tests and Prevalence of Cognitive Impairment According to
Level of Moderate to Vigorous Physical Activity, Race, and Sex
Variable
Quartile 1 Quartile 2 Quartile 3 Quartile 4
P-ValueMean (Standard Error)
Average overall cognitive z-score (N = 5,188)a
Black male –0.70 (0.05) –0.49 (0.05) –0.35 (0.05) –0.40 (0.06) <.001d
Black female –0.35 (0.04) –0.21 (0.04) –0.27 (0.05) –0.15 (0.06) .30
White male –0.44 (0.04) –0.28 (0.04) –0.22 (0.03) –0.14 (0.03) <.001d
White female –0.08 (0.03) 0.06 (0.03) 0.01 (0.04) 0.08 (0.04) .06
Executive function z-score (N = 4,441)b
Black male –0.56 (0.07) –0.38 (0.07) –0.35 (0.07) –0.32 (0.08) .50
Black female –0.48 (0.05) –0.42 (0.05) –0.49 (0.06) –0.39 (0.08) .99
White male –0.32 (0.05) –0.18 (0.05) –0.08 (0.04) 0.01 (0.04) <.001e
White female –0.13 (0.04) –0.03 (0.04) –0.02 (0.05) 0.14 (0.05) <.001d
Memory z-score (N = 5,178)c
Black male –0.74 (0.07) –0.48 (0.06) –0.32 (0.07) –0.38 (0.07) <.001d
Black female –0.23 (0.04) –0.03 (0.05) –0.10 (0.06) 0.01 (0.08) .27
White male –0.52 (0.05) –0.32 (0.04) –0.26 (0.04) –0.20 (0.04) <.001d
White female –0.02 (0.04) 0.14 (0.04) 0.05 (0.04) 0.08 (0.05) .14
Adjusted for age, region, education, proportion of time spent sedentary, body mass index, hypertension, smoking, and diabetes mellitus.
Cognitive impairment is defined as a score of ≤4 correct responses on six-item screener (three-item recall and three-item temporal orientation).
Quartiles denote proportion of total time spent in moderate to vigorous physical activity.
aAverage cognitive z-score refers to average of mean executive score and mean memory score. The reference of the z-score is the mean and standard devia-
tion (SD) of the total sample.
bExecutive z-score refers to average of standardized scores of letter fluency and animal fluency tests. For participants with only one executive test, mean
score would be the result of that test. The reference of the z-score is the mean and SD of the total sample.
cMemory z-score refers to average of standardized scores of word list learning and Montreal Cognitive Assessment five-word delayed memory recall and
six-item orientation tests. For participants with only one executive test, the mean score would be the result of that test. The reference of the z-score is the
mean and SD of the total sample.
dP < .05 between Quartiles 1 and 3 and Quartiles 1 and 4.
eP < .05 between Quartiles 1 and 3.
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association between PA and cognitive function in a large
population of older adults. This allowed for analyses with
absolute amount and proportion of time spent in PA of
varying intensity. Second, this is one of the first studies to
examine the association between objectively measured PA
and cognitive function in a diverse population, providing
more-detailed analyses for older white and black women
and men. Finally, it was possible to explore the relationship
between accelerometer-derived PA and sedentary behavior
in specific domains of memory and executive function in
addition to odds of impairment in global cognitive status.
The findings of this study were also subject to limita-
tions. First, the study was an attempt to characterize par-
ticipants’ habitual PA using accelerometers. A limitation
of using accelerometers is that type of PA activity and
upper body movements are not captured. Second, because
this was a cross-sectional analysis, causality cannot be
inferred. Third, because of the potential for unaccounted
confounding factors and random errors or noise in the
dataset, the results should be interpreted with caution.
Last, because of the excessive skewness of MVPA (min/
wk) and MVPA% as continuous variables, it was not
possible to identify a precise threshold for reducing the
risk of cognitive impairment or the degree of risk reduc-
tion associated with a minor increase in daily or weekly
MVPA. It is possible that a MVPA level higher than of
participants in Quartile 3 (11.1 min/d) and less than that
observed for Quartile 4 (36.9 min/d) is adequate to
reduce the risk of cognitive decline in older adults. Fur-
ther studies are warranted in this arena to help refine PA
guidelines.
In summary, higher levels of objectively measured
MVPA% were independently associated with less likeli-
hood of cognitive impairment and better performance in
memory and executive function for white and black older
adults. In addition, there was a dose-response relationship
between MVPA% and cognitive function in older adults,
with the highest level of MVPA% associated with better
cognitive function. The amount of MVPA associated with
lower prevalence of cognitive impairment is consistent
with meeting U.S. PA guidelines. Neither LPA% nor ST%
was associated with any measure of cognitive function in
this cohort, which warrants further investigation.
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